Answers are grounded in this paper and cite their sources.
Risk stratification for primary prevention ICDs in ARVC requires an iterative approach, regular reassessment of disease phenotype, and shared decision-making.
Schematic summarising the iterative, stepwise approach to risk stratification in ARVC. The dynamic nature of the disease requires regular reassessment of disease phenotype. Decisions on primary prevention implantable cardioverter defibrillators (ICDs) should take into account aetiology as well as putative clinical risk markers. In every case, shared decision making with respect to ICD therapy and life-style choices is essential.
No takes yet. Share an insight, caveat, or question.
Perry Elliott (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: